Ticagrelor plus aspirin does not improve rates of death, myocardial infarction (MI), stroke or repeat revascularization compared with aspirin alone in patients who undergo coronary artery bypass grafting (CABG) for acute coronary syndrome (ACS), results from the Swedish TACSI trial show.